These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6298429)

  • 1. (Mercaptopropanoyl)indoline-2-carboxylic acids and related compounds as potent angiotensin converting enzyme inhibitors and antihypertensive agents.
    Kim DH; Guinosso CJ; Buzby GC; Herbst DR; McCaully RJ; Wicks TC; Wendt RL
    J Med Chem; 1983 Mar; 26(3):394-403. PubMed ID: 6298429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl)carbonyl]-L-prolines.
    Ciabatti R; Padova G; Bellasio E; Tarzia G; Depaoli A; Battaglia F; Cellentani M; Barone D; Baldoli E
    J Med Chem; 1986 Mar; 29(3):411-7. PubMed ID: 3005576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive agents: angiotensin converting enzyme inhibitors. 1-[3-(Acylthio)-3-aroylpropionyl]-L-prolines.
    McEvoy FJ; Lai FM; Albright JD
    J Med Chem; 1983 Mar; 26(3):381-93. PubMed ID: 6298428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.
    Krapcho J; Turk C; Cushman DW; Powell JR; DeForrest JM; Spitzmiller ER; Karanewsky DS; Duggan M; Rovnyak G; Schwartz J
    J Med Chem; 1988 Jun; 31(6):1148-60. PubMed ID: 2836590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives.
    Hayashi K; Nunami K; Kato J; Yoneda N; Kubo M; Ochiai T; Ishida R
    J Med Chem; 1989 Feb; 32(2):289-97. PubMed ID: 2913292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitory and antihypertensive activities of pivalopril (RHC 3659-(S)).
    Wolf PS; Mann WS; Suh JT; Loev B; Smith RD
    Fed Proc; 1984 Apr; 43(5):1322-5. PubMed ID: 6323222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acids derivatives.
    Gruenfeld N; Stanton JL; Yuan AM; Ebetino FH; Browne LJ; Gude C; Huebner CF
    J Med Chem; 1983 Sep; 26(9):1277-82. PubMed ID: 6310113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
    Nambu K; Matsumoto K; Takeyama K; Hosoki K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):47-51. PubMed ID: 3006710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
    Li GH; Qu MR; Wan JZ; You JM
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives.
    Suh JT; Skiles JW; Williams BE; Youssefyeh RD; Jones H; Loev B; Neiss ES; Schwab A; Mann WS; Khandwala A
    J Med Chem; 1985 Jan; 28(1):57-66. PubMed ID: 2981324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors: N-substituted D-glutamic acid gamma dipeptides.
    Ksander GM; Yuan AM; Diefenbacher CG; Stanton JL
    J Med Chem; 1985 Nov; 28(11):1606-11. PubMed ID: 2999395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives.
    Stanton JL; Gruenfeld N; Babiarz JE; Ackerman MH; Friedmann RC; Yuan AM; Macchia W
    J Med Chem; 1983 Sep; 26(9):1267-77. PubMed ID: 6310112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors: synthesis and biological activity of N-substituted tripeptide inhibitors.
    Sawayama T; Tsukamoto M; Sasagawa T; Nishimura K; Deguchi T; Takeyama K; Hosoki K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):110-5. PubMed ID: 2159850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.